Recent Updates
Recently added Catalysts
JNJ Positive Sentiment

Johnson & Johnson to Participate in the 2026 Wells Fargo Healthcare Conference

Tuesday, August 4, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Johnson & Johnson will participate in the 2026 Wells Fargo Healthcare Conference on September 9th, 2026. The company's management is scheduled to engage in a Fireside Chat at 11:00 a.m. Eastern Time. Investors can access a live audio webcast of the presentation through the company's Investor Relations website, with an archived edition available later.

Market Sentiment Analysis

POSITIVE FACTORS

  • Johnson & Johnson is actively engaging with investors.
  • Participation in a prominent healthcare conference highlights company visibility.
  • The event provides a platform for management to communicate directly with stakeholders.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.6%
average across 15 past catalysts
Lead asset
Tapentadol
Phase 3 · Osteoarthritis, Hip

Full Press Release Details

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) will present at the 2026 Wells Fargo Healthcare Conference on Wednesday, September 9th, 2026. Management will participate in a Fireside Chat at 11:00 a.m. Eastern Time. A live audio webcast of the presentation will be accessible through Johnson & Johnson’s Investor Relations website at www.investor.jnj.com. An archived edition of the session will be available later that day. The audio webcast replay will be available ap

Frequently Asked Questions

When will Johnson & Johnson present at the conference?

Johnson & Johnson will present on September 9th, 2026.

What time is the Fireside Chat scheduled?

The Fireside Chat is scheduled for 11:00 a.m. Eastern Time.

How can investors access the presentation?

Investors can access the live audio webcast on Johnson & Johnson's Investor Relations website.

Will there be a replay of the presentation?

Yes, an archived edition of the session will be available later that day.

ShareAdd on Google
Tags: JNJ Viatris Investor Conferences Healthcare Johnson & Johnson Wells Fargo healthcare conference investor relations Fireside Chat
Last updated: Aug 4, 2026

Biotech snapshot

Cash runway
$20758M liquidity · $0M/mo burn
Low dilution risk
Lead asset
TapentadolPhase 3
Osteoarthritis, Hip →

Catalyst track record

+34%
best trade around JNJ's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for JNJ.

See every catalyst's timing & PoA →